Skip to content

Rogers Corporation ROG Free cash flow

Free cash flow at other companies

3M logo
3MMMM
$349M+211%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-$67.23M-23.0%
Biogen logo
BiogenBIIB
$594.3M+167%
Chemours logo
ChemoursCC
-$93M+52.6%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
Entegris logo
EntegrisENTG

Other financials

Income statement

See full
Revenue$200.5M+5.2%
Gross profit$64.6M+13.3%
Operating income$10.7M+3,667%
Net income$4.5M+421%
EPS (diluted)$0.25+413%

Balance sheet

See full
Cash & equivalents$195.8M+11.5%
Total debt$29.8M-10.5%
Total equity$1.2B-6.1%
Total assets$1.4B-5.6%

Cash flow

See full
Operating cash flow$5.8M-50.4%
CapEx$4.7M-51.0%

Valuation

See full
Market cap$2.84B+53.1%
Enterprise value$2.67B+57.7%
P/S3.5×+1.2×

Profitability

See full
Gross margin32.2%-0.7pp
Operating margin8.1%-6.7pp
Net margin-7.4%-9.5pp
FCF margin8.5%+1.8pp

Returns & leverage

See full
Return on equity-4.9%-6.3pp
Debt / equity0.0×
Current ratio+0.1×

Where this comes from

Calculated from Rogers Corporation’s reported figures.

The official record: Rogers Corporation’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rogers Corporation's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rogers Corporation's free cash flow?
Rogers Corporation (ROG) reported free cash flow of $1.1M in Q1 2026.
How has Rogers Corporation's free cash flow changed year-over-year?
Rogers Corporation's free cash flow decreased by 47.6% year-over-year, from $2.1M to $1.1M.
What is the long-term trend for Rogers Corporation's free cash flow?
Over 3 years (2022 to 2025), Rogers Corporation's free cash flow has grown at a 77.6% compound annual growth rate (CAGR), from $12.7M to $71.1M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.